Stay updated on Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section wording updated to indicate PubMed publications are automatically filled and may not be about the study, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding status notice was removed from the Study Details page; all primary study content remains the same.SummaryDifference0.3%

- Check35 days agoChange DetectedThe updates seem to involve only minor UI layout adjustments and wording edits across the page, with no changes to the study design, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check71 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. No substantive changes to core content, pricing, stock, or time slot availability.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.